The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma.

BACKGROUND Obesity has been associated to increased hepatocellular carcinoma (HCC) risk, but studies on the topic do not fully account for hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. Likewise, an increased risk has been reported for diabetes mellitus (DM) but whether DM is an independent risk factor has not been established yet. To evaluate the association of obesity and DM with HCC risk, we conducted a hospital-based, case-control study in two Italian areas. PATIENTS AND METHODS From 1999 to 2003, 185 HCC cases and 404 hospital controls were enrolled. Blood samples were obtained for HBV and HCV screening. RESULTS After allowance for known risk factors, body mass index >/=30 kg/m(2) [odds ratio (OR) = 1.9, 95% confidence interval (CI) 0.9-3.9] and DM (OR = 3.7, 95% CI 1.7-8.4) were associated to HCC risk. These associations persisted (OR = 3.5, 95% CI 1.6-7.7 for obesity; OR = 3.5, 95% CI 1.3-9.2 for DM) among subjects without HBV and/or HCV infection. Overall, 23% of HCC cases seemed attributable to these conditions, and this figure rose to 37% among subjects without HBV and/or HCV infections. CONCLUSIONS The present study provides further evidence that obesity and DM increase HCC risk and that these factors may explain a relevant proportion of cases among subjects without markers of HBV/HCV infection.

[1]  M. Zwahlen,et al.  Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies , 2008, The Lancet.

[2]  S. Larsson,et al.  Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies , 2007, British Journal of Cancer.

[3]  R. Beasley Diabetes and hepatocellular carcinoma , 2006, Hepatology.

[4]  N. Ganne-Carrié,et al.  Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  M. Lai,et al.  Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection , 2006, Hepatology.

[6]  C. la Vecchia,et al.  Hepatitis Viruses, Alcohol, and Tobacco in the Etiology of Hepatocellular Carcinoma in Italy , 2006, Cancer Epidemiology Biomarkers & Prevention.

[7]  S. Caldwell,et al.  Obesity and hepatocellular carcinoma. , 2004, Gastroenterology.

[8]  H. El‐Serag,et al.  Hepatocellular carcinoma: recent trends in the United States. , 2004, Gastroenterology.

[9]  Jian-Min Yuan,et al.  Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. , 2004, Cancer.

[10]  E. Negri,et al.  Non‐Hodgkin's lymphoma and hepatitis C virus: A case‐control study from northern and southern Italy , 2004, International journal of cancer.

[11]  E. Abdalla,et al.  Obesity and diabetes as a risk factor for hepatocellular carcinoma , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[12]  A. Burroughs,et al.  Hepatocellular carcinoma , 2003, The Lancet.

[13]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference , 2003, Hepatology.

[14]  H. Senn,et al.  Insulin-like growth factors and cancer. , 2002, The Lancet. Oncology.

[15]  C. la Vecchia,et al.  Reliability of data on medical conditions, menstrual and reproductive history provided by hospital controls. , 2001, Journal of clinical epidemiology.

[16]  H. Adami,et al.  Role of diabetes mellitus in the etiology of hepatocellular carcinoma. , 2000, Journal of the National Cancer Institute.

[17]  C. la Vecchia,et al.  Trends in mortality from primary liver cancer in Europe. , 2000, European journal of cancer.

[18]  R. Wiesner,et al.  Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. , 2000, Journal of hepatology.

[19]  N. Turkçapar,et al.  Association of diabetes mellitus and chronic hepatitis C virus infection , 1999, Hepatology.

[20]  C. la Vecchia,et al.  Diabetes mellitus and the risk of primary liver cancer , 1997 .

[21]  M Linet,et al.  Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. , 1997, Journal of the National Cancer Institute.

[22]  H. Adami,et al.  Excess risk of primary liver cancer in patients with diabetes mellitus. , 1996, Journal of the National Cancer Institute.

[23]  J Benichou,et al.  Software for attributable risk and confidence interval estimation in case-control studies. , 1996, Computers and biomedical research, an international journal.

[24]  Mashhood Ali,et al.  Diabetes mellitus in chronic active hepatitis and cirrhosis , 1984 .

[25]  N. Breslow,et al.  Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .

[26]  Italian cancer figures--report 2006: 1. Incidence, mortality and estimates. , 2006, Epidemiologia e prevenzione.

[27]  H. Hsu,et al.  Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients , 1994, Cancer.

[28]  N E Day,et al.  Statistical methods in cancer research. IARC Workshop 25-27 May 1983. , 1987, IARC scientific publications.

[29]  N. Breslow,et al.  The analysis of case-control studies , 1980 .